These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8049452)

  • 21. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation.
    Locasciulli A; Bacigalupo A; VanLint MT; Cavalletto D; Pontisso P; Testa M; Masera G; Shulman HM; Portmann B; Alberti A
    Bone Marrow Transplant; 1995 Sep; 16(3):407-11. PubMed ID: 8535314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
    Remberger M; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT.
    Duggan C; Schmidt M; Lawler M; White B; Cusack S; McCann S; Smith O
    Bone Marrow Transplant; 1999 Sep; 24(6):693-4. PubMed ID: 10490739
    [No Abstract]   [Full Text] [Related]  

  • 27. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation.
    Bertheau P; Parquet N; Ferchal F; Gluckman E; Brocheriou C
    Bone Marrow Transplant; 1996 Feb; 17(2):295-8. PubMed ID: 8640184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation.
    Locasciulli A; Testa M; Pontisso P; Bacigalupo A; Ljungman P; Frickhofen N; Alberti A
    Bone Marrow Transplant; 1997 Feb; 19(3):237-40. PubMed ID: 9028552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genotype of hepatitis C virus does not affect severity of liver disease after bone marrow transplantation.
    Locasciulli A; Pontisso P; Alberti A; Bacigalupo A; Ljungman P; Frickhofen N
    Blood; 1995 May; 85(9):2640. PubMed ID: 7727791
    [No Abstract]   [Full Text] [Related]  

  • 31. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
    Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
    Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
    Terra SG; Spitzer TR; Tsunoda SM
    Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
    Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic bone marrow transplantation: acute and late complications.
    Tabbara IA
    Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schistosomiasis as a predisposing factor to veno-occlusive disease of the liver following allogeneic bone marrow transplantation.
    Mahmoud HK
    Bone Marrow Transplant; 1996 Mar; 17(3):401-3. PubMed ID: 8704694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
    Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hepatic veno-occlusive disease (VOD) in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematology Oncology Association-Bone Marrow Transplantation Group) Centers.
    Miniero R; Vassallo E; Soldano S; Nesi F; Vai S; Balduzzi A; Varotto S; Dallorso S; Prete A; Arcese W
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():157-9. PubMed ID: 8932820
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
    Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
    Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
    Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
    Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.